• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺腺癌:导管起源癌及胰腺上皮内瘤变的外科病理学进展

Pancreatic adenocarcinoma: update on the surgical pathology of carcinomas of ductal origin and PanINs.

作者信息

Hruban Ralph H, Fukushima Noriyoshi

机构信息

Departments of Pathology and Oncology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.

出版信息

Mod Pathol. 2007 Feb;20 Suppl 1:S61-70. doi: 10.1038/modpathol.3800685.

DOI:10.1038/modpathol.3800685
PMID:17486053
Abstract

Pancreatic cancer is the fourth leading cause of cancer death in the US. Most pancreatic cancers are infiltrating ductal adenocarcinomas. The careful application of well-defined morphologic criteria can be used to differentiate between infiltrating ductal adenocarcinoma and reactive glands. While most pancreatic cancers are ductal adenocarcinomas, a number of histologically defined variants have been described. These are important to recognize because they have distinct clinical pathologic features. Pancreatic intraepithelial neoplasia (PanIN) is the presumed precursor lesion to infiltrating ductal adenocarcinoma, and PanIN lesions can mimic infiltrating cancer.

摘要

胰腺癌是美国癌症死亡的第四大主要原因。大多数胰腺癌是浸润性导管腺癌。仔细应用明确的形态学标准可用于区分浸润性导管腺癌和反应性腺。虽然大多数胰腺癌是导管腺癌,但已描述了一些组织学定义的变体。识别这些变体很重要,因为它们具有独特的临床病理特征。胰腺上皮内瘤变(PanIN)被认为是浸润性导管腺癌的前驱病变,并且PanIN病变可能会模仿浸润性癌。

相似文献

1
Pancreatic adenocarcinoma: update on the surgical pathology of carcinomas of ductal origin and PanINs.胰腺腺癌:导管起源癌及胰腺上皮内瘤变的外科病理学进展
Mod Pathol. 2007 Feb;20 Suppl 1:S61-70. doi: 10.1038/modpathol.3800685.
2
Lack of apoptosis in PanIN-1 and PanIN-2 lesions associated with pancreatic ductal adenocarcinoma is not dependent on K-ras status.与胰腺导管腺癌相关的PanIN-1和PanIN-2病变中凋亡的缺失不依赖于K-ras状态。
Pancreas. 2003 Oct;27(3):e57-62. doi: 10.1097/00006676-200310000-00021.
3
Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer.Kras 突变率精确地协调了导管衍生的胰腺上皮内瘤变和胰腺癌。
Lab Invest. 2021 Feb;101(2):177-192. doi: 10.1038/s41374-020-00490-5. Epub 2020 Oct 2.
4
[Precursors to pancreatic cancer].[胰腺癌的前驱病变]
Tidsskr Nor Laegeforen. 2006 Mar 23;126(7):905-8.
5
[Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma].胰腺上皮内瘤变(PanIN)和导管内乳头状黏液性肿瘤(IPMN)作为胰腺癌的前驱病变
Med Klin (Munich). 2007 Feb 15;102(2):127-35. doi: 10.1007/s00063-007-1013-8.
6
Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs).胰腺癌的形态发生:胰腺上皮内瘤变(PanINs)的作用。
Langenbecks Arch Surg. 2008 Jul;393(4):561-70. doi: 10.1007/s00423-008-0282-x. Epub 2008 Feb 19.
7
Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia.端粒缩短在胰腺上皮内瘤变中几乎普遍存在。
Am J Pathol. 2002 Nov;161(5):1541-7. doi: 10.1016/S0002-9440(10)64432-X.
8
Where and when does pancreatic carcinoma start?胰腺癌始于何处,始于何时?
Med Klin (Munich). 2004 Apr 15;99(4):191-5. doi: 10.1007/s00063-004-1028-3.
9
Can we predict the progression of premalignant pancreatic cystic tumors to ductal adenocarcinoma?我们能否预测癌前胰腺囊性肿瘤向导管腺癌的进展?
Future Oncol. 2022 Jul;18(23):2605-2612. doi: 10.2217/fon-2021-1545. Epub 2022 Jun 22.
10
Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia.腺泡细胞促成胰腺上皮内瘤变的分子异质性。
Am J Pathol. 2007 Jul;171(1):263-73. doi: 10.2353/ajpath.2007.061176.

引用本文的文献

1
The diagnostic value of LncRNA NEAT1 targeting miR-129-5p in pancreatic cancer patients.LncRNA NEAT1靶向miR-129-5p在胰腺癌患者中的诊断价值。
Sci Rep. 2025 Jul 29;15(1):27638. doi: 10.1038/s41598-025-12963-y.
2
SSH3 promotes pancreatic cancer proliferation and migration by activating the notch signaling pathway.SSH3通过激活Notch信号通路促进胰腺癌的增殖和迁移。
Am J Cancer Res. 2024 Apr 15;14(4):1815-1830. doi: 10.62347/DAZV7194. eCollection 2024.
3
A Somatic BRCA2-Mutated Pancreatic Adenocarcinoma With Sustained Exceptional Response to Modified FOLFIRINOX.
BRCA2 种系突变的胰腺腺泡细胞癌伴改良 FOLFIRINOX 方案持续获得完全缓解
Oncologist. 2024 Apr 4;29(4):350-355. doi: 10.1093/oncolo/oyad315.
4
Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma.致癌性KRAS在胰腺导管腺癌中引发代谢重编程。
J Transl Int Med. 2022 Nov 15;11(4):322-329. doi: 10.2478/jtim-2022-0022. eCollection 2023 Dec.
5
Three-dimensional analysis of human pancreatic cancer specimens by phase-contrast based X-ray tomography - the next dimension of diagnosis.基于相衬 X 射线断层摄影术的人类胰腺癌标本的三维分析——诊断的下一个维度。
Cancer Imaging. 2023 May 2;23(1):43. doi: 10.1186/s40644-023-00559-6.
6
Development and external validation of a dynamic nomogram to predict the survival for adenosquamous carcinoma of the pancreas.用于预测胰腺腺鳞癌生存率的动态列线图的开发与外部验证
Front Oncol. 2022 Aug 12;12:927107. doi: 10.3389/fonc.2022.927107. eCollection 2022.
7
High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancer.p62/SQSTM1 高表达预示胰腺癌患者生存时间更短。
BMC Cancer. 2022 Mar 30;22(1):347. doi: 10.1186/s12885-022-09468-6.
8
Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors.自噬有助于代谢重编程和胰腺肿瘤的治疗抵抗。
Cells. 2022 Jan 26;11(3):426. doi: 10.3390/cells11030426.
9
A Dangerous Mimic: Chronic Pancreatitis Masquerading As Pancreatic Adenocarcinoma.一种危险的伪装:伪装成胰腺腺癌的慢性胰腺炎。
Cureus. 2021 Nov 21;13(11):e19795. doi: 10.7759/cureus.19795. eCollection 2021 Nov.
10
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition).流式细胞术和细胞分选在免疫学研究中的应用指南(第三版)。
Eur J Immunol. 2021 Dec;51(12):2708-3145. doi: 10.1002/eji.202170126. Epub 2021 Dec 7.